Moderna, Inc. (MRNA) on Wednesday announced that it will bring drug product manufacturing to its existing Moderna Technology ...

The new plant will allow the company to execute end-to-end clinical- and commercial-stage production of its mRNA medicines.

The company reported $200 million in net losses for the third quarter, but an aggressive and highly successful cost-cutting ...

With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.

Moderna (MRNA) announced on Wednesday that it has completed its domestic end-to-end mRNA manufacturing network with the ...

Moderna's CEO says that people will likely need a fourth dose of a COVID-19 vaccine later this year. According to The Washington Post and CNBC, Moderna CEO Stéphane Bancel said at a conference hosted ...

Dec 2 (Reuters) - Moderna Inc's (MRNA.O), opens new tab COVID-19 vaccine could be approved for emergency use within 24 to 72 hours after the U.S. health regulator's advisory committee meeting, Chief ...

Moderna on Thursday said it plans to slash roughly 10% of its global workforce by the end of the year, as Covid shot sales continue to dwindle and the company grapples with uncertainty in the vaccine ...

Dec 4 (Reuters) - Moderna Inc (MRNA.O), opens new tab will be able to produce 500 million doses of its COVID-19 vaccine in 2021, Chief Executive Officer Stéphane Bancel said on Friday. The company has ...